GAM Holding AG increased its stake in shares of Iqvia Holdings Inc (NYSE:IQV) by 182.7% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 8,567 shares of the medical research company’s stock after buying an additional 5,537 shares during the quarter. GAM Holding AG’s holdings in Iqvia were worth $1,111,000 at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in the stock. Nomura Asset Management Co. Ltd. lifted its position in Iqvia by 1.9% during the third quarter. Nomura Asset Management Co. Ltd. now owns 25,186 shares of the medical research company’s stock worth $3,268,000 after buying an additional 461 shares in the last quarter. IFM Investors Pty Ltd lifted its position in Iqvia by 5.4% during the third quarter. IFM Investors Pty Ltd now owns 9,290 shares of the medical research company’s stock worth $1,205,000 after buying an additional 478 shares in the last quarter. State Treasurer State of Michigan lifted its position in Iqvia by 1.0% during the third quarter. State Treasurer State of Michigan now owns 48,300 shares of the medical research company’s stock worth $6,266,000 after buying an additional 500 shares in the last quarter. Independent Advisor Alliance lifted its position in Iqvia by 4.9% during the third quarter. Independent Advisor Alliance now owns 11,240 shares of the medical research company’s stock worth $1,455,000 after buying an additional 525 shares in the last quarter. Finally, Gateway Investment Advisers LLC lifted its position in Iqvia by 9.1% during the third quarter. Gateway Investment Advisers LLC now owns 6,770 shares of the medical research company’s stock worth $878,000 after buying an additional 563 shares in the last quarter. Hedge funds and other institutional investors own 89.33% of the company’s stock.
NYSE:IQV opened at $117.98 on Friday. Iqvia Holdings Inc has a 52 week low of $91.57 and a 52 week high of $135.48. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 1.41. The firm has a market capitalization of $24.38 billion, a price-to-earnings ratio of 24.03, a price-to-earnings-growth ratio of 1.75 and a beta of 0.81.
Iqvia (NYSE:IQV) last posted its earnings results on Monday, October 22nd. The medical research company reported $1.42 EPS for the quarter, beating the Zacks’ consensus estimate of $1.39 by $0.03. The company had revenue of $2.59 billion for the quarter, compared to the consensus estimate of $2.58 billion. Iqvia had a return on equity of 13.69% and a net margin of 12.29%. The company’s quarterly revenue was up 5.2% compared to the same quarter last year. On average, research analysts predict that Iqvia Holdings Inc will post 5.13 EPS for the current fiscal year.
A number of equities analysts recently commented on the company. Robert W. Baird lifted their price objective on Iqvia from $143.00 to $146.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 2nd. UBS Group initiated coverage on Iqvia in a research report on Tuesday, October 9th. They issued a “buy” rating on the stock. Raymond James lifted their target price on Iqvia from $136.00 to $145.00 and gave the company a “strong-buy” rating in a research report on Friday, August 31st. Morgan Stanley lifted their target price on Iqvia from $130.00 to $145.00 and gave the company an “overweight” rating in a research report on Monday, December 3rd. Finally, Argus set a $136.00 target price on Iqvia and gave the company a “buy” rating in a research report on Thursday, August 23rd. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. Iqvia currently has a consensus rating of “Buy” and a consensus price target of $134.41.
In related news, Director Group Holdings (Sbs) Advis Tpg sold 3,573,545 shares of the business’s stock in a transaction on Tuesday, December 4th. The stock was sold at an average price of $123.72, for a total value of $442,118,987.40. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, major shareholder Canada Pension Plan Investment sold 3,164,388 shares of the business’s stock in a transaction on Tuesday, December 4th. The shares were sold at an average price of $123.72, for a total value of $391,498,083.36. The disclosure for this sale can be found here. Insiders sold a total of 7,117,903 shares of company stock worth $881,082,166 in the last quarter. Company insiders own 6.00% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “GAM Holding AG Has $1.11 Million Position in Iqvia Holdings Inc (IQV)” was first posted by American Banking News and is the property of of American Banking News. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at https://www.americanbankingnews.com/2018/12/08/gam-holding-ag-has-1-11-million-position-in-iqvia-holdings-inc-iqv.html.
IQVIA Holdings Inc provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offers a range of cloud-based applications and related implementation, real-world insights, and reference information services; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.
Further Reading: Return on Equity (ROE)
Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Iqvia Holdings Inc (NYSE:IQV).
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.